Literature DB >> 30410213

Dry eye disease: when to treat and when to refer.

Quan Findlay1,2,3, Kate Reid1,2,3.   

Abstract

Entities:  

Keywords:  aqueous deficiency dry eye; evaporative dry eye; meibomian gland dysfunction

Year:  2018        PMID： 30410213      PMCID： PMC6202299          DOI： 10.18773/austprescr.2018.048

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  10 in total

Review 1.  Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease.

Authors:  Marta Sacchetti; Flavio Mantelli; Alessandro Lambiase; Alessandra Mastropasqua; Daniela Merlo; Stefano Bonini
Journal:  Br J Ophthalmol       Date:  2013-12-16       Impact factor: 4.638

Review 2.  TFOS DEWS II Definition and Classification Report.

Authors:  Jennifer P Craig; Kelly K Nichols; Esen K Akpek; Barbara Caffery; Harminder S Dua; Choun-Ki Joo; Zuguo Liu; J Daniel Nelson; Jason J Nichols; Kazuo Tsubota; Fiona Stapleton
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

3.  Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study.

Authors:  Michael A Lemp; Leslie A Crews; Anthony J Bron; Gary N Foulks; Benjamin D Sullivan
Journal:  Cornea       Date:  2012-05       Impact factor: 2.651

Review 4.  Clinical staining of the ocular surface: mechanisms and interpretations.

Authors:  A J Bron; P Argüeso; M Irkec; F V Bright
Journal:  Prog Retin Eye Res       Date:  2014-10-23       Impact factor: 21.198

5.  Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.

Authors:  Elisabeth M Messmer; Victoria von Lindenfels; Alexandra Garbe; Anselm Kampik
Journal:  Ophthalmology       Date:  2016-09-21       Impact factor: 12.079

Review 6.  Autologous serum for ocular surface diseases.

Authors:  Guilherme Goulart Quinto; Mauro Campos; Ashley Behrens
Journal:  Arq Bras Oftalmol       Date:  2008 Nov-Dec       Impact factor: 0.872

Review 7.  Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review.

Authors:  Michael J Doughty; Sara Glavin
Journal:  Ophthalmic Physiol Opt       Date:  2009-08-14       Impact factor: 3.117

8.  Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops.

Authors:  Empar Sanz-Marco; Patricia Udaondo; Salvador García-Delpech; Amparo Vazquez; Manuel Diaz-Llopis
Journal:  J Ocul Pharmacol Ther       Date:  2013-08-15       Impact factor: 2.671

Review 9.  Dry Eye Syndrome in Menopause and Perimenopausal Age Group.

Authors:  Travis Peck; Leslie Olsakovsky; Shruti Aggarwal
Journal:  J Midlife Health       Date:  2017 Apr-Jun

Review 10.  Intense pulsed light for evaporative dry eye disease.

Authors:  Steven J Dell
Journal:  Clin Ophthalmol       Date:  2017-06-20
  10 in total
  8 in total

1.  Dry eye: serum eye drops.

Authors:  Phillip Mondy
Journal:  Aust Prescr       Date:  2019-02-01

2.  Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion.

Authors:  Cynthia Matossian; William Trattler; Jennifer Loh
Journal:  Clin Ophthalmol       Date:  2021-05-11

3.  Assessment of tear film in subjects with a high body mass index.

Authors:  Saud A Alanazi
Journal:  Clin Optom (Auckl)       Date:  2019-07-26

4.  Trends in the Utilization of Sodium Hyaluronate Eye Drops, Including Disposable and Multiuse Forms, in South Korea: A 14-Year Longitudinal Retrospective Cohort Study.

Authors:  Kyung-Bok Son
Journal:  Front Pharmacol       Date:  2020-05-15       Impact factor: 5.810

Review 5.  Therapeutic Ophthalmic Lenses: A Review.

Authors:  N Toffoletto; B Saramago; A P Serro
Journal:  Pharmaceutics       Date:  2020-12-28       Impact factor: 6.321

Review 6.  Adenosine receptors as promising targets for the management of ocular diseases.

Authors:  Eleonora Spinozzi; Cecilia Baldassarri; Laura Acquaticci; Fabio Del Bello; Mario Grifantini; Loredana Cappellacci; Petrelli Riccardo
Journal:  Med Chem Res       Date:  2021-01-25       Impact factor: 2.351

7.  Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects.

Authors:  Joo Young Na; Ki Young Huh; Kyung-Sang Yu; Joon Young Hyon; Hye Cheong Koo; Jong Ho Lee; Ji Chang You; Jae-Yong Chung
Journal:  Clin Transl Sci       Date:  2022-02-08       Impact factor: 4.438

8.  Identified risk factors for dry eye syndrome: A systematic review and meta-analysis.

Authors:  Lijun Qian; Wei Wei
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.